Hi all,
As a psychiatrist, I have several patients with anxiety disorders who seem to experience ongoing benefit with benzodiazepine treatment despite long-term use. It makes me wonder if there can be some sort of differential tolerance—where tolerance to euphoria occurs but not the central therapeutic effect of the medication.
In your clinical experience with chronic pain patients refractory to first-line medications, could you share whether patients started on low-dose opiates inevitably require higher and higher dosages? Or have you observed a subset that respond well at a relatively low dose and find lasting benefit?
Thanks guys.
As a psychiatrist, I have several patients with anxiety disorders who seem to experience ongoing benefit with benzodiazepine treatment despite long-term use. It makes me wonder if there can be some sort of differential tolerance—where tolerance to euphoria occurs but not the central therapeutic effect of the medication.
In your clinical experience with chronic pain patients refractory to first-line medications, could you share whether patients started on low-dose opiates inevitably require higher and higher dosages? Or have you observed a subset that respond well at a relatively low dose and find lasting benefit?
Thanks guys.